Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
批准号:
G0500950/1
负责人:
Alexander Medvinsky
金额:
$59.65万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
这项研究计划的主要焦点是一种名为AML1/RUNX1的基因对血液干细胞的发育和调控。干细胞是当前生物学研究的主要焦点之一,因为干细胞具有自我复制和分化为多种成熟细胞的能力。AML1/RUNX1对成人血液系统的发育至关重要,并经常参与人类白血病的发生。AML1/RUNX1基因产生不同形式的蛋白质,可以竞争影响其他参与干细胞发育和功能的基因,以及白血病的发生。我们已经产生了基因改变的胚胎干细胞和小鼠实验系统,允许人工调节AML1/RUNX1基因。AML1/RUNX1基因的调控是通过现代双组分四环素诱导系统实现的。该系统的设计能够微调细胞中AML1/RUNX1蛋白的水平。这些AML1/RUNX1蛋白的影响将在培养的ES细胞、发育中的小鼠胚胎和成年小鼠中进行研究。另外两只带有由AML1/RUNX1控制的荧光标记基因的转基因小鼠也将被用于这项研究,以实现对表达AML1蛋白的细胞的准确识别。更好地理解干细胞调节和AML1在这一过程中的作用将对制定实用的再生医学方案具有潜在的意义。
英文摘要
The main focus of this research proposal is in the development and regulation of blood stem cells by a gene called AML1/Runx1. Stem cells are one of the main foci of current biology due to their potential to self-replicate and give rise to a variety of mature cells. AML1/Runx1 is critically important for the development of the adult blood system and is frequently involved in the development of human leukaemias. AML1/Runx1 gene produces different forms of the protein which can compete for the influence on other genes which are involved in stem cell development and function as well in the development of leukaemias. We have generated genetically altered embryonic stem (ES) cells and mouse experimental systems which allow AML1/Runx1 gene to be artificially regulated. Regulation of AML1/Runx1 gene is achieved by the use of a modern bi-component tetracycline inducible system. The design of the system enables fine tuning of levels of the AML1/Runx1 protein in cells. The influence of these AML1/Runx1 proteins will be studied in cultured ES cells as well as in developing mouse embryos and in the adult mouse. Two additional genetically modified mice which have fluorescent tagged genes controlled by AML1/Runx1 will also be used in this research to enable accurate identification of cells which express AML1 protein. Better understanding of stem cell regulation and the role of AML1 in this process will have potential implications for the development of protocols for practical regenerative medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
-
批准号:MR/W029669/1
-
项目类别:Research Grant
-
资助金额:$214.79万
-
财政年份:2023
-
负责人:Alexander Medvinsky
-
依托单位:
Analysis of biomechanical forces in the embryonic development of haematopoietic stem cells
-
批准号:BB/W003236/1
-
项目类别:Research Grant
-
资助金额:$92.08万
-
财政年份:2022
-
负责人:Alexander Medvinsky
-
依托单位:
UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING DEVELOPMENT OF HIGHLY REGENERATIVE HUMAN HAEMATOPOIETIC STEM CELLS
-
批准号:MR/V030043/1
-
项目类别:Research Grant
-
资助金额:$91.8万
-
财政年份:2021
-
负责人:Alexander Medvinsky
-
依托单位:
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
-
批准号:MR/R018081/1
-
项目类别:Research Grant
-
资助金额:$80.62万
-
财政年份:2018
-
负责人:Alexander Medvinsky
-
依托单位:
Tracking the embryonic origin of the adult haematopoietic system
-
批准号:MR/L018160/1
-
项目类别:Research Grant
-
资助金额:$101.23万
-
财政年份:2014
-
负责人:Alexander Medvinsky
-
依托单位:
DEVELOPMENT OF A NON-INVASIVE STRATEGY ENHANCING HAEMATOPOIETIC STEM CELL (HSC) POTENTIAL OF HUMAN UMBILICAL CORD CELLS
-
批准号:G0901577/1
-
项目类别:Research Grant
-
资助金额:$88.88万
-
财政年份:2011
-
负责人:Alexander Medvinsky
-
依托单位:
Identification of functional domains in the AGM region linked to the hierarchical organisation of the developing haematopoietic stem cell lineage
-
批准号:BB/H008780/1
-
项目类别:Research Grant
-
资助金额:$164.57万
-
财政年份:2010
-
负责人:Alexander Medvinsky
-
依托单位:
ANALYSIS OF MECHANISMS OF EARLY HAEMATOPOIETIC STEM CELL DEVELOPMENT CONTROLLED BY FLK1/SCL REGULATORY NETWORK
-
批准号:G0900962/1
-
项目类别:Research Grant
-
资助金额:$158.35万
-
财政年份:2010
-
负责人:Alexander Medvinsky
-
依托单位:
The analysis of cellular mechanisms underlying haematopoietic stem cell (HSC) development using a novel in vitro system
-
批准号:BB/D01347X/1
-
项目类别:Research Grant
-
资助金额:$51.61万
-
财政年份:2006
-
负责人:Alexander Medvinsky
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AML1/ETO-FTO-IGFBP2轴在t(8;21)急性髓系白血病化疗耐药中的机理研究
-
批准号:82070161
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:李永辉
-
依托单位:
环状RNA CDR1-AS通过上调融合基因AML1/ETO表达促进急性髓细胞白血病发生发展的分子机制
-
批准号:81900161
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:吕逸竹
-
依托单位:
AML1/ETO融合基因通过APP和AML1/ETO9a协同C-KIT基因突变促发白血病的研究
-
批准号:81500138
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:余国攀
-
依托单位:
mRNA甲基化调控儿童TEL/AML1阳性急性淋巴细胞白血病发生发展机制研究
-
批准号:81470339
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:竺晓凡
-
依托单位:
miR-144靶向APP调控AML1/ETO+白血病细胞髓外浸润的实验研究
-
批准号:81400103
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:蒋玲
-
依托单位:
转录因子AML1特异性募集组蛋白修饰酶MLL在白血病发病机制中的作用
-
批准号:81000220
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:和夫红
-
依托单位:
急性髓系白血病RARα、AML1、MLL基因断裂融合的新筛选方法的建立及相关伙伴基因的克隆与鉴定
-
批准号:30772064
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:王宏伟
-
依托单位:
转录因子GATA2和AML1基因突变在慢粒急变发生机制中的研究
-
批准号:30500298
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2005
-
负责人:施静艺
-
依托单位:
CD34scFv介导的siRNA靶向抑制白血病干细胞AML1/ETO基因表达及其对细胞生长和分化的影响
-
批准号:30570784
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:王光平
-
依托单位:
AML1/ETO融合蛋白抑制基因转录的研究
-
批准号:39970317
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:1999
-
负责人:王建祥
-
依托单位: